{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T11:00:40Z","timestamp":1792839640067,"version":"4.5.0"},"reference-count":214,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T00:00:00Z","timestamp":1743379200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100017950","name":"Shanghai Municipal Health Commission","doi-asserted-by":"publisher","award":["2024CXJQ01"],"award-info":[{"award-number":["2024CXJQ01"]}],"id":[{"id":"10.13039\/100017950","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82371817"],"award-info":[{"award-number":["82371817"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.autrev.2025.103806","type":"journal-article","created":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T20:30:49Z","timestamp":1742848249000},"page":"103806","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Role of regulatory T cells in inflammatory liver diseases"],"prefix":"10.1016","volume":"24","author":[{"given":"Linjie","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song Guo","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"17","key":"10.1016\/j.autrev.2025.103806_bb0005","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1056\/NEJMoa2029349","article-title":"Prospective study of outcomes in adults with nonalcoholic fatty liver disease","volume":"385","author":"Sanyal","year":"2021","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.autrev.2025.103806_bb0010","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1136\/gutjnl-2020-322786","article-title":"Mortality in biopsy-confirmed nonalcoholic fatty liver disease: results from a nationwide cohort","volume":"70","author":"Tracey","year":"2021","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.autrev.2025.103806_bb0015","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1007\/s10620-021-07009-y","article-title":"Liver fibrosis in the natural course of chronic hepatitis B viral infection: a systematic review with Meta-analysis","volume":"67","author":"Lin","year":"2022","journal-title":"Dig Dis Sci"},{"issue":"9865","key":"10.1016\/j.autrev.2025.103806_bb0020","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S0140-6736(12)61425-1","article-title":"Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study","volume":"381","author":"Marcellin","year":"2013","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.autrev.2025.103806_bb0025","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1016\/j.jhep.2020.08.006","article-title":"Hepatic benefits of HCV cure","volume":"73","author":"Calvaruso","year":"2020","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.autrev.2025.103806_bb0030","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1053\/j.gastro.2015.04.005","article-title":"Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis","volume":"149","author":"Vilar-Gomez","year":"2015","journal-title":"Gastroenterology"},{"issue":"10390","key":"10.1016\/j.autrev.2025.103806_bb0035","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1016\/S0140-6736(23)00634-7","article-title":"Bariatric-metabolic surgery versus lifestyle intervention plus best medical care in non-alcoholic steatohepatitis (BRAVES): a multicentre, open-label, randomised trial","volume":"401","author":"Verrastro","year":"2023","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.autrev.2025.103806_bb0040","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1365-2249.2005.02840.x","article-title":"The paradox of matrix metalloproteinases in infectious disease","volume":"142","author":"Elkington","year":"2005","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"10.1016\/j.autrev.2025.103806_bb0045","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41423-020-00558-8","article-title":"Hepatic macrophages in liver homeostasis and diseases-diversity, plasticity and therapeutic opportunities","volume":"18","author":"Wen","year":"2021","journal-title":"Cell Mol Immunol"},{"issue":"3","key":"10.1016\/j.autrev.2025.103806_bb0050","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1172\/JCI30542","article-title":"Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ","volume":"117","author":"Iredale","year":"2007","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.autrev.2025.103806_bb0055","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.4049\/jimmunol.155.3.1151","article-title":"Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases","volume":"155","author":"Sakaguchi","year":"1995","journal-title":"J Immunol"},{"issue":"8","key":"10.1016\/j.autrev.2025.103806_bb0060","doi-asserted-by":"crossref","first-page":"4183","DOI":"10.4049\/jimmunol.169.8.4183","article-title":"Generation ex vivo of TGF-\u03b2-producing regulatory T cells from CD4+CD25\u2212 precursors","volume":"169","author":"Zheng","year":"2002","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.autrev.2025.103806_bb0065","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.4049\/jimmunol.172.3.1531","article-title":"CD4+ and CD8+ regulatory T cells generated ex vivo with IL-2 and TGF-\u03b2 suppress a stimulatory graft-versus-host disease with a lupus-like syndrome","volume":"172","author":"Zheng","year":"2004","journal-title":"J Immunol"},{"issue":"10","key":"10.1016\/j.autrev.2025.103806_bb0070","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1038\/ni.2402","article-title":"Transcription factor Foxp3 and its protein partners form a complex regulatory network","volume":"13","author":"Rudra","year":"2012","journal-title":"Nat Immunol"},{"issue":"10","key":"10.1016\/j.autrev.2025.103806_bb0075","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1038\/ni.2420","article-title":"A multiply redundant genetic switch \u2018locks in\u2019 the transcriptional signature of regulatory T cells","volume":"13","author":"Fu","year":"2012","journal-title":"Nat Immunol"},{"issue":"9","key":"10.1016\/j.autrev.2025.103806_bb0080","doi-asserted-by":"crossref","first-page":"5213","DOI":"10.4049\/jimmunol.172.9.5213","article-title":"Natural and induced CD4+CD25+ cells educate CD4+CD25\u2212 cells to develop suppressive activity: the role of IL-2, TGF-\u03b2, and IL-10","volume":"172","author":"Zheng","year":"2004","journal-title":"J Immunol"},{"issue":"8","key":"10.1016\/j.autrev.2025.103806_bb0085","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1097\/MIB.0b013e318281f5a3","article-title":"Induced and natural regulatory T cells in the development of inflammatory bowel disease","volume":"19","author":"Mayne","year":"2013","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.autrev.2025.103806_bb0090","series-title":"T regulatory cells in human health and diseases","first-page":"1","article-title":"Regulatory T cells: Concept, classification, phenotype, and biological characteristics","author":"Du","year":"2021"},{"issue":"3","key":"10.1016\/j.autrev.2025.103806_bb0095","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nri1032","article-title":"Natural versus adaptive regulatory T cells","volume":"3","author":"Bluestone","year":"2003","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"10.1016\/j.autrev.2025.103806_bb0100","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/ni.2554","article-title":"Regulatory T cells: recommendations to simplify the nomenclature","volume":"14","author":"Abbas","year":"2013","journal-title":"Nat Immunol"},{"issue":"5","key":"10.1016\/j.autrev.2025.103806_bb0105","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.immuni.2009.05.002","article-title":"Natural and adaptive Foxp3+ regulatory T cells: more of the same or a division of labor?","volume":"30","author":"Curotto de Lafaille","year":"2009","journal-title":"Immunity"},{"issue":"12","key":"10.1016\/j.autrev.2025.103806_bb0110","doi-asserted-by":"crossref","first-page":"7282","DOI":"10.4049\/jimmunol.166.12.7282","article-title":"A role for TGF-\u03b2 in the generation and expansion of CD4+CD25+ regulatory T cells from human peripheral Blood1","volume":"166","author":"Yamagiwa","year":"2001","journal-title":"J Immunol"},{"issue":"12","key":"10.1016\/j.autrev.2025.103806_bb0115","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/ni1265","article-title":"Inducing and expanding regulatory T cell populations by foreign antigen","volume":"6","author":"Kretschmer","year":"2005","journal-title":"Nat Immunol"},{"issue":"6","key":"10.1016\/j.autrev.2025.103806_bb0120","doi-asserted-by":"crossref","first-page":"3321","DOI":"10.4049\/jimmunol.176.6.3321","article-title":"TGF-\u03b2 requires CTLA-4 early after T cell activation to induce FoxP3 and generate adaptive CD4+CD25+ regulatory cells","volume":"176","author":"Zheng","year":"2006","journal-title":"J Immunol"},{"issue":"9","key":"10.1016\/j.autrev.2025.103806_bb0125","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.it.2008.06.005","article-title":"Natural and TGF-beta-induced Foxp3(+)CD4(+) CD25(+) regulatory T cells are not mirror images of each other","volume":"29","author":"Horwitz","year":"2008","journal-title":"Trends Immunol"},{"issue":"5","key":"10.1016\/j.autrev.2025.103806_bb0130","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1182\/blood-2008-05-078154","article-title":"CD4 T cells: fates, functions, and faults","volume":"112","author":"Zhu","year":"2008","journal-title":"Blood"},{"issue":"5955","key":"10.1016\/j.autrev.2025.103806_bb0135","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1126\/science.1172702","article-title":"CD4+ regulatory T cells control TH17 responses in a Stat3-dependent manner","volume":"326","author":"Chaudhry","year":"2009","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.autrev.2025.103806_bb0140","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1038\/nm.2426","article-title":"Follicular regulatory T cells expressing Foxp3 and Bcl-6 suppress germinal center reactions","volume":"17","author":"Chung","year":"2011","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.autrev.2025.103806_bb0145","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/83713","article-title":"The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3","volume":"27","author":"Bennett","year":"2001","journal-title":"Nat Genet"},{"issue":"4","key":"10.1016\/j.autrev.2025.103806_bb0150","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/ni904","article-title":"Foxp3 programs the development and function of CD4+CD25+ regulatory T cells","volume":"4","author":"Fontenot","year":"2003","journal-title":"Nat Immunol"},{"issue":"4","key":"10.1016\/j.autrev.2025.103806_bb0155","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/ni1180","article-title":"Mechanisms of suppression by suppressor T cells","volume":"6","author":"von Boehmer","year":"2005","journal-title":"Nat Immunol"},{"issue":"7","key":"10.1016\/j.autrev.2025.103806_bb0160","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nri2343","article-title":"How regulatory T cells work","volume":"8","author":"Vignali","year":"2008","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"10.1016\/j.autrev.2025.103806_bb0165","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1002\/eji.200738109","article-title":"Critical role of IL-2 and TGF-\u03b2 in generation, function and stabilization of Foxp3+CD4+ Treg","volume":"38","author":"Horwitz","year":"2008","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.autrev.2025.103806_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2020.102461","article-title":"The progress and prospect of regulatory T cells in autoimmune diseases","volume":"111","author":"Zhang","year":"2020","journal-title":"J Autoimmun"},{"issue":"11","key":"10.1016\/j.autrev.2025.103806_bb0175","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1038\/s41423-021-00764-y","article-title":"TGF-\u03b2-induced CD4+ FoxP3+ regulatory T cell-derived extracellular vesicles modulate Notch1 signaling through miR-449a and prevent collagen-induced arthritis in a murine model","volume":"18","author":"Chen","year":"2021","journal-title":"Cell Mol Immunol"},{"issue":"10","key":"10.1016\/j.autrev.2025.103806_bb0180","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2020-218762","article-title":"Response to: Correspondence to: Combination of human umbilical cord mesenchymal stem cell transplantation with IFN-\u03b3 treatment synergistically improves the clinical outcomes of patients with rheumatoid arthritis by Ma <em>et al<\/em&gt","volume":"81","author":"Yang","year":"2022","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.autrev.2025.103806_bb0185","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.4049\/jimmunol.178.4.2018","article-title":"IL-2 is essential for TGF-\u03b2 to convert naive CD4+CD25\u2212 cells to CD25+Foxp3+ regulatory T cells and for expansion of these cells","volume":"178","author":"Zheng","year":"2007","journal-title":"J Immunol"},{"issue":"7","key":"10.1016\/j.autrev.2025.103806_bb0190","doi-asserted-by":"crossref","first-page":"4022","DOI":"10.4049\/jimmunol.178.7.4022","article-title":"Cutting edge: IL-2 is essential for TGF-\u03b2-mediated induction of Foxp3+ T regulatory cells","volume":"178","author":"Davidson","year":"2007","journal-title":"J Immunol"},{"issue":"12","key":"10.1016\/j.autrev.2025.103806_bb0195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0015150","article-title":"Characterization of protective human CD4+CD25+ FOXP3+ regulatory T cells generated with IL-2, TGF-\u03b2 and retinoic acid","volume":"5","author":"Lu","year":"2010","journal-title":"PloS One"},{"issue":"9","key":"10.1016\/j.autrev.2025.103806_bb0200","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0024590","article-title":"All-trans retinoic acid promotes TGF-\u03b2-induced Tregs via histone modification but not DNA demethylation on Foxp3 gene locus","volume":"6","author":"Lu","year":"2011","journal-title":"PloS One"},{"issue":"2","key":"10.1016\/j.autrev.2025.103806_bb0205","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1189\/jlb.0513297","article-title":"Differential role of all-trans retinoic acid in promoting the development of CD4+ and CD8+ regulatory T cells","volume":"95","author":"Ma","year":"2014","journal-title":"J Leukoc Biol"},{"issue":"33","key":"10.1016\/j.autrev.2025.103806_bb0210","doi-asserted-by":"crossref","first-page":"E3432","DOI":"10.1073\/pnas.1408780111","article-title":"Critical role of all-trans retinoic acid in stabilizing human natural regulatory T cells under inflammatory conditions","volume":"111","author":"Lu","year":"2014","journal-title":"Proc Natl Acad Sci"},{"issue":"5","key":"10.1016\/j.autrev.2025.103806_bb0215","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/pr.2015.143","article-title":"The role of Th17 and Treg responses in the pathogenesis of RSV infection","volume":"78","author":"Mangodt","year":"2015","journal-title":"Pediatr Res"},{"issue":"11","key":"10.1016\/j.autrev.2025.103806_bb0220","doi-asserted-by":"crossref","first-page":"6725","DOI":"10.4049\/jimmunol.178.11.6725","article-title":"Cutting edge: regulatory T cells induce CD4+CD25\u2212Foxp3\u2212 T cells or are self-induced to become Th17 cells in the absence of exogenous TGF-\u03b2","volume":"178","author":"Xu","year":"2007","journal-title":"J Immunol"},{"issue":"11","key":"10.1016\/j.autrev.2025.103806_bb0225","doi-asserted-by":"crossref","first-page":"7112","DOI":"10.4049\/jimmunol.180.11.7112","article-title":"Cutting edge: Foxp3+CD4+CD25+ regulatory T cells induced by IL-2 and TGF-\u03b2 are resistant to Th17 conversion by IL-6","volume":"180","author":"Zheng","year":"2008","journal-title":"J Immunol"},{"issue":"8","key":"10.1016\/j.autrev.2025.103806_bb0230","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1002\/art.34513","article-title":"Antigen-specific transforming growth factor \u03b2-induced Treg cells, but not natural Treg cells, ameliorate autoimmune arthritis in mice by shifting the Th17\/Treg cell balance from Th17 predominance to Treg cell predominance","volume":"64","author":"Kong","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.autrev.2025.103806_bb0235","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1136\/annrheumdis-2011-201052","article-title":"Induced T regulatory cells suppress osteoclastogenesis and bone erosion in collagen-induced arthritis better than natural T regulatory cells","volume":"71","author":"Kong","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.autrev.2025.103806_bb0240","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.clim.2008.12.008","article-title":"IL-1\u03b2 and IL-2 convert human Treg into TH17 cells","volume":"131","author":"Deknuydt","year":"2009","journal-title":"Clin Immunol"},{"issue":"44","key":"10.1016\/j.autrev.2025.103806_bb0245","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abb0606","article-title":"Induced, but not natural, regulatory T cells retain phenotype and function following exposure to inflamed synovial fibroblasts","volume":"6","author":"Yang","year":"2025","journal-title":"Sci Adv"},{"issue":"7","key":"10.1016\/j.autrev.2025.103806_bb0250","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1016\/j.celrep.2019.01.066","article-title":"Negligible effect of sodium chloride on the development and function of TGF-\u03b2-induced CD4+ Foxp3+ regulatory T cells","volume":"26","author":"Luo","year":"2019","journal-title":"Cell Rep"},{"issue":"2","key":"10.1016\/j.autrev.2025.103806_bb0255","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.immuni.2023.01.004","article-title":"Principles of regulatory T cell function","volume":"56","author":"Dikiy","year":"2023","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.autrev.2025.103806_bb0260","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.immuni.2011.03.005","article-title":"Autocrine transforming growth factor-\u03b21 promotes in vivo Th17 cell differentiation","volume":"34","author":"Gutcher","year":"2011","journal-title":"Immunity"},{"issue":"9","key":"10.1016\/j.autrev.2025.103806_bb0265","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/ni1504","article-title":"Regulatory T cells expressing interleukin 10 develop from Foxp3+ and Foxp3- precursor cells in the absence of interleukin 10","volume":"8","author":"Maynard","year":"2007","journal-title":"Nat Immunol"},{"issue":"6","key":"10.1016\/j.autrev.2025.103806_bb0270","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.immuni.2006.09.013","article-title":"Expression of interleukin-10 in intestinal lymphocytes detected by an interleukin-10 reporter knockin tiger mouse","volume":"25","author":"Kamanaka","year":"2006","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.autrev.2025.103806_bb0275","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1084\/jem.20062512","article-title":"Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression","volume":"204","author":"Deaglio","year":"2007","journal-title":"J Exp Med"},{"issue":"2","key":"10.1016\/j.autrev.2025.103806_bb0280","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.jaci.2012.05.011","article-title":"Induced CD4+ forkhead box protein-positive T cells inhibit mast cell function and established contact hypersensitivity through TGF-\u03b21","volume":"130","author":"Su","year":"2012","journal-title":"J Allergy Clin Immunol"},{"issue":"8","key":"10.1016\/j.autrev.2025.103806_bb0285","doi-asserted-by":"crossref","first-page":"3878","DOI":"10.4049\/jimmunol.1201029","article-title":"Dendritic cell-specific disruption of TGF-\u03b2 receptor II leads to altered regulatory T cell phenotype and spontaneous multiorgan autoimmunity","volume":"189","author":"Ramalingam","year":"2012","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.autrev.2025.103806_bb0290","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1093\/jmcb\/mjs040","article-title":"Polyclonal CD4+Foxp3+ Treg cells induce TGF\u03b2-dependent tolerogenic dendritic cells that suppress the murine lupus-like syndrome","volume":"4","author":"Lan","year":"2012","journal-title":"J Mol Cell Biol"},{"issue":"11","key":"10.1016\/j.autrev.2025.103806_bb0295","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1016\/j.ymthe.2019.07.014","article-title":"CD8+CD103+ iTregs inhibit chronic graft-versus-host disease with lupus nephritis by the increased expression of CD39","volume":"27","author":"Zhang","year":"2019","journal-title":"Mol Ther"},{"issue":"6","key":"10.1016\/j.autrev.2025.103806_bb0300","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.4049\/jimmunol.1801306","article-title":"The cAMP\u2013adenosine feedback loop maintains the suppressive function of regulatory T cells","volume":"203","author":"Su","year":"2019","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.autrev.2025.103806_bb0305","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.immuni.2008.02.017","article-title":"Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces","volume":"28","author":"Rubtsov","year":"2008","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.autrev.2025.103806_bb0310","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.stem.2018.01.017","article-title":"CD150(high) bone marrow Tregs maintain hematopoietic stem cell quiescence and immune privilege via adenosine","volume":"22","author":"Hirata","year":"2018","journal-title":"Cell Stem Cell"},{"issue":"3","key":"10.1016\/j.autrev.2025.103806_bb0315","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.cell.2008.07.025","article-title":"TGF-beta: a master of all T cell trades","volume":"134","author":"Li","year":"2008","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.autrev.2025.103806_bb0320","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.molmed.2013.03.005","article-title":"CD39 and CD73 in immunity and inflammation","volume":"19","author":"Antonioli","year":"2013","journal-title":"Trends Mol Med"},{"issue":"3","key":"10.1016\/j.autrev.2025.103806_bb0325","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/nri2711","article-title":"The regulation of IL-10 production by immune cells","volume":"10","author":"Saraiva","year":"2010","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"10.1016\/j.autrev.2025.103806_bb0330","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.immuni.2008.02.017","article-title":"Regulatory T cell-derived Interleukin-10 limits inflammation at environmental interfaces","volume":"28","author":"Rubtsov","year":"2008","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.autrev.2025.103806_bb0335","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.immuni.2016.01.013","article-title":"Interleukin-35 limits anti-tumor immunity","volume":"44","author":"Turnis","year":"2016","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.autrev.2025.103806_bb0340","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.immuni.2016.01.013","article-title":"Interleukin-35 limits anti-tumor immunity","volume":"44","author":"Turnis","year":"2016","journal-title":"Immunity"},{"issue":"5","key":"10.1016\/j.autrev.2025.103806_bb0345","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20200795","article-title":"Lymph node fibroblastic reticular cells regulate differentiation and function of CD4 T cells via CD25","volume":"219","author":"Kim","year":"2022","journal-title":"J Exp Med"},{"issue":"7601","key":"10.1016\/j.autrev.2025.103806_bb0350","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nature17947","article-title":"EBI2 augments Tfh cell fate by promoting interaction with IL-2-quenching dendritic cells","volume":"533","author":"Li","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2025.103806_bb0355","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1146\/annurev-immunol-032712-095956","article-title":"Metabolic Regulation of T Lymphocytes","volume":"31","author":"MacIver","year":"2013","journal-title":"Annu Rev Immunol"},{"issue":"1","key":"10.1016\/j.autrev.2025.103806_bb0360","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.it.2014.08.003","article-title":"Metabolic control of regulatory T cell development and function","volume":"36","author":"Zeng","year":"2015","journal-title":"Trends Immunol"},{"issue":"6","key":"10.1016\/j.autrev.2025.103806_bb0365","doi-asserted-by":"crossref","first-page":"3299","DOI":"10.4049\/jimmunol.1003613","article-title":"Cutting edge: distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4+ T cell subsets","volume":"186","author":"Michalek","year":"2011","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.autrev.2025.103806_bb0370","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.cmet.2019.11.021","article-title":"Mitochondrial integrity regulated by lipid metabolism is a cell-intrinsic checkpoint for Treg suppressive function","volume":"31","author":"Field","year":"2020","journal-title":"Cell Metab"},{"issue":"12","key":"10.1016\/j.autrev.2025.103806_bb0375","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1038\/ni.3577","article-title":"Foxp3 and toll-like receptor signaling balance Treg cell anabolic metabolism for suppression","volume":"17","author":"Gerriets","year":"2016","journal-title":"Nat Immunol"},{"key":"10.1016\/j.autrev.2025.103806_bb0380","first-page":"10","article-title":"6-Phosphogluconate dehydrogenase (6PGD), a key checkpoint in reprogramming of regulatory T cells metabolism and function","author":"Daneshmandi","year":"2021","journal-title":"Elife"},{"issue":"5","key":"10.1016\/j.autrev.2025.103806_bb0385","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/s42255-022-00575-z","article-title":"Non-oxidative pentose phosphate pathway controls regulatory T cell function by integrating metabolism and epigenetics","volume":"4","author":"Liu","year":"2022","journal-title":"Nat Metab"},{"issue":"5","key":"10.1016\/j.autrev.2025.103806_bb0390","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/ni.3390","article-title":"Phosphatase PP2A is requisite for the function of regulatory T cells","volume":"17","author":"Apostolidis","year":"2016","journal-title":"Nat Immunol"},{"issue":"786","key":"10.1016\/j.autrev.2025.103806_bb0395","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adp4447","article-title":"Gluconolactone restores immune regulation and alleviates skin inflammation in lupus-prone mice and in patients with cutaneous lupus","volume":"17","author":"Li","year":"2025","journal-title":"Sci Transl Med"},{"issue":"7404","key":"10.1016\/j.autrev.2025.103806_bb0400","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/nature11132","article-title":"PPAR-\u03b3 is a major driver of the accumulation and phenotype of adipose tissue Treg cells","volume":"486","author":"Cipolletta","year":"2012","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.autrev.2025.103806_bb0405","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.stem.2018.01.017","article-title":"CD150high bone marrow Tregs maintain hematopoietic stem cell quiescence and immune privilege via adenosine","volume":"22","author":"Hirata","year":"2018","journal-title":"Cell Stem Cell"},{"issue":"6","key":"10.1016\/j.autrev.2025.103806_bb0410","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.cell.2017.05.002","article-title":"Regulatory T cells in skin facilitate epithelial stem cell differentiation","volume":"169","author":"Ali","year":"2017","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.autrev.2025.103806_bb0415","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.cell.2015.08.021","article-title":"A distinct function of regulatory T cells in tissue protection","volume":"162","author":"Arpaia","year":"2015","journal-title":"Cell"},{"issue":"7580","key":"10.1016\/j.autrev.2025.103806_bb0420","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/nature16151","article-title":"Depletion of fat-resident Treg cells prevents age-associated insulin resistance","volume":"528","author":"Bapat","year":"2015","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.autrev.2025.103806_bb0425","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.cell.2013.10.054","article-title":"A special population of regulatory T cells potentiates muscle repair","volume":"155","author":"Burzyn","year":"2013","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.autrev.2025.103806_bb0430","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1038\/nm.2002","article-title":"Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters","volume":"15","author":"Feuerer","year":"2009","journal-title":"Nat Med"},{"issue":"7738","key":"10.1016\/j.autrev.2025.103806_bb0435","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/s41586-018-0824-5","article-title":"Brain regulatory T cells suppress astrogliosis and potentiate neurological recovery","volume":"565","author":"Ito","year":"2019","journal-title":"Nature"},{"issue":"39","key":"10.1016\/j.autrev.2025.103806_bb0440","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aaw2910","article-title":"Regulatory T cells in skin are uniquely poised to suppress profibrotic immune responses","volume":"4","author":"Kalekar","year":"2019","journal-title":"Sci Immunol"},{"issue":"3","key":"10.1016\/j.autrev.2025.103806_bb0445","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.immuni.2019.02.013","article-title":"Treg-cell control of a CXCL5-IL-17 inflammatory Axis promotes hair-follicle-stem-cell differentiation during skin-barrier repair","volume":"50","author":"Mathur","year":"2019","journal-title":"Immunity"},{"issue":"7","key":"10.1016\/j.autrev.2025.103806_bb0450","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1038\/s41590-022-01244-9","article-title":"Glucocorticoid signaling and regulatory T cells cooperate to maintain the hair-follicle stem-cell niche","volume":"23","author":"Liu","year":"2022","journal-title":"Nat Immunol"},{"issue":"6","key":"10.1016\/j.autrev.2025.103806_bb0455","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.devcel.2017.11.010","article-title":"Zebrafish regulatory T cells mediate organ-specific regenerative programs","volume":"43","author":"Hui","year":"2017","journal-title":"Dev Cell"},{"issue":"7","key":"10.1016\/j.autrev.2025.103806_bb0460","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S0025-6196(24)00530-5","article-title":"Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease","volume":"55","author":"Ludwig","year":"1980","journal-title":"Mayo Clin Proc"},{"issue":"7","key":"10.1016\/j.autrev.2025.103806_bb0465","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.autrev.2025.103806_bb0470","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J Hepatol"},{"issue":"Suppl","key":"10.1016\/j.autrev.2025.103806_bb0475","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.3350\/cmh.2022.0367","article-title":"MAFLD: how is it different from NAFLD?","volume":"29","author":"Gofton","year":"2023","journal-title":"Clin Mol Hepatol"},{"issue":"1","key":"10.1016\/j.autrev.2025.103806_bb0480","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1146\/annurev-pathol-020117-043617","article-title":"Recent insights into the pathogenesis of nonalcoholic fatty liver disease","volume":"13","author":"Arab","year":"2018","journal-title":"Annu Rev Pathol Mech Dis"},{"issue":"1","key":"10.1016\/j.autrev.2025.103806_bb0485","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1146\/annurev-pathol-012615-044224","article-title":"Nonalcoholic fatty liver disease: pathogenesis and disease Spectrum","volume":"11","author":"Hardy","year":"2016","journal-title":"Annu Rev Pathol Mech Dis"},{"key":"10.1016\/j.autrev.2025.103806_bb0490","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23020652","article-title":"Tacke the potential role of cellular senescence in non-alcoholic fatty liver disease","volume":"23","author":"Engelmann","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.autrev.2025.103806_bb0495","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/S0016-5085(98)70599-2","article-title":"Steatohepatitis: a tale of two \u201chits\u201d?","volume":"114","author":"Day","year":"1998","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1016\/j.autrev.2025.103806_bb0500","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1136\/jcp.2011.090175","article-title":"Participation of bile ductular cells in the pathological progression of non-alcoholic fatty liver disease","volume":"64","author":"Mayumi","year":"2011","journal-title":"J Clin Pathol"},{"issue":"9","key":"10.1016\/j.autrev.2025.103806_bb0505","doi-asserted-by":"crossref","DOI":"10.1172\/JCI132305","article-title":"Bile acid-activated macrophages promote biliary epithelial cell proliferation through integrin \u03b1v\u03b26 upregulation following liver injury","volume":"131","author":"Guillot","year":"2021","journal-title":"J Clin Invest"},{"issue":"8","key":"10.1016\/j.autrev.2025.103806_bb0510","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1038\/s42255-023-00863-2","article-title":"The pentose phosphate pathway in health and disease","volume":"5","author":"TeSlaa","year":"2023","journal-title":"Nat Metab"},{"issue":"7","key":"10.1016\/j.autrev.2025.103806_bb0515","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1016\/j.biocel.2009.02.001","article-title":"Transaldolase: from biochemistry to human disease","volume":"41","author":"Samland","year":"2009","journal-title":"Int J Biochem Cell Biol"},{"issue":"6","key":"10.1016\/j.autrev.2025.103806_bb0520","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1172\/JCI35722","article-title":"Prevention of hepatocarcinogenesis and increased susceptibility to acetaminophen-induced liver failure in transaldolase-deficient mice by N-acetylcysteine","volume":"119","author":"Hanczko","year":"2009","journal-title":"J Clin Invest"},{"issue":"7","key":"10.1016\/j.autrev.2025.103806_bb0525","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.molmed.2011.01.014","article-title":"Oxidative stress, inflammation and carcinogenesis are controlled through the pentose phosphate pathway by transaldolase","volume":"17","author":"Perl","year":"2011","journal-title":"Trends Mol Med"},{"issue":"11","key":"10.1016\/j.autrev.2025.103806_bb0530","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0026644","article-title":"Interleukin-1 as an injury signal mobilizes Retinyl esters in hepatic stellate cells through down regulation of lecithin retinol acyltransferase","volume":"6","author":"Kida","year":"2011","journal-title":"PloS One"},{"issue":"6","key":"10.1016\/j.autrev.2025.103806_bb0535","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/jmcb\/mjt042","article-title":"Restoration of intrahepatic regulatory T cells through MMP-9\/13-dependent activation of TGF-\u03b2 is critical for immune homeostasis following acute liver injury","volume":"5","author":"Lu","year":"2013","journal-title":"J Mol Cell Biol"},{"issue":"6","key":"10.1016\/j.autrev.2025.103806_bb0540","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41575-018-0009-6","article-title":"Triggering and resolution of inflammation in NASH","volume":"15","author":"Schuster","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.autrev.2025.103806_bb0545","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/nm.2667","article-title":"Macrophage-derived Wnt opposes notch signaling to specify hepatic progenitor cell fate in chronic liver disease","volume":"18","author":"Boulter","year":"2012","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.autrev.2025.103806_bb0550","doi-asserted-by":"crossref","first-page":"8096","DOI":"10.1038\/srep08096","article-title":"Dysbiosis gut microbiota associated with inflammation and impaired mucosal immune function in intestine of humans with non-alcoholic fatty liver disease","volume":"5","author":"Jiang","year":"2015","journal-title":"Sci Rep"},{"issue":"7593","key":"10.1016\/j.autrev.2025.103806_bb0555","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nature16969","article-title":"NAFLD causes selective CD4+ T lymphocyte loss and promotes hepatocarcinogenesis","volume":"531","author":"Ma","year":"2016","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.autrev.2025.103806_bb0560","doi-asserted-by":"crossref","first-page":"97","DOI":"10.4049\/jimmunol.1501175","article-title":"Progression from nonalcoholic fatty liver to nonalcoholic steatohepatitis is marked by a higher frequency of Th17 cells in the liver and an increased Th17\/resting regulatory T cell ratio in peripheral blood and in the liver","volume":"196","author":"Rau","year":"2016","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.autrev.2025.103806_bb0565","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1002\/hep.21823","article-title":"A high-fat diet and regulatory T cells influence susceptibility to endotoxin-induced liver injury","volume":"46","author":"Ma","year":"2007","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.autrev.2025.103806_bb0570","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/s41575-019-0210-2","article-title":"Adaptive immunity: an emerging player in the progression of NAFLD","volume":"17","author":"Sutti","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.autrev.2025.103806_bb0575","first-page":"9","article-title":"Obesity, fat mass and immune system: role for leptin","author":"Francisco","year":"2018","journal-title":"Front Physiol"},{"issue":"2","key":"10.1016\/j.autrev.2025.103806_bb0580","article-title":"The detrimental role of regulatory T cells in nonalcoholic steatohepatitis. Hepatology","volume":"6","author":"Dywicki","year":"2022","journal-title":"Communications"},{"issue":"6","key":"10.1016\/j.autrev.2025.103806_bb0585","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.jhep.2021.07.032","article-title":"Regulatory T-cell and neutrophil extracellular trap interaction contributes to carcinogenesis in non-alcoholic steatohepatitis","volume":"75","author":"Wang","year":"2021","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.autrev.2025.103806_bb0590","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.immuni.2024.01.009","article-title":"Amphiregulin from regulatory T cells promotes liver fibrosis and insulin resistance in non-alcoholic steatohepatitis","volume":"57","author":"Savage","year":"2024","journal-title":"Immunity"},{"issue":"23","key":"10.1016\/j.autrev.2025.103806_bb0595","doi-asserted-by":"crossref","DOI":"10.1172\/JCI175305","article-title":"The Nr4a family regulates intrahepatic Treg proliferation and liver fibrosis in MASLD models","volume":"134","author":"Aki","year":"2024","journal-title":"J Clin Invest"},{"issue":"9","key":"10.1016\/j.autrev.2025.103806_bb0600","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1038\/s41590-021-01010-3","article-title":"Insulin signaling establishes a developmental trajectory of adipose regulatory T cells","volume":"22","author":"Li","year":"2021","journal-title":"Nat Immunol"},{"issue":"7790","key":"10.1016\/j.autrev.2025.103806_bb0605","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/s41586-019-1865-0","article-title":"Microbial bile acid metabolites modulate gut ROR\u03b3+ regulatory T cell homeostasis","volume":"577","author":"Song","year":"2020","journal-title":"Nature"},{"issue":"7785","key":"10.1016\/j.autrev.2025.103806_bb0610","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/s41586-019-1785-z","article-title":"Bile acid metabolites control TH17 and Treg cell differentiation","volume":"576","author":"Hang","year":"2019","journal-title":"Nature"},{"issue":"7809","key":"10.1016\/j.autrev.2025.103806_bb0615","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/s41586-020-2193-0","article-title":"Bacterial metabolism of bile acids promotes generation of peripheral regulatory T cells","volume":"581","author":"Campbell","year":"2020","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.autrev.2025.103806_bb0620","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.jhep.2015.06.030","article-title":"Autoimmune hepatitis","volume":"63","author":"EASL Clinical Practice Guidelines","year":"2015","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.autrev.2025.103806_bb0625","doi-asserted-by":"crossref","first-page":"18017","DOI":"10.1038\/nrdp.2018.17","article-title":"Autoimmune hepatitis","volume":"4","author":"Mieli-Vergani","year":"2018","journal-title":"Nat Rev Dis Primers"},{"issue":"6957","key":"10.1016\/j.autrev.2025.103806_bb0630","first-page":"1323","article-title":"Lupoid hepatitis","volume":"271","author":"Cowling","year":"1956","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.autrev.2025.103806_bb0635","doi-asserted-by":"crossref","DOI":"10.1002\/hep.31065","article-title":"Diagnosis and Management of Autoimmune Hepatitis in adults and children: 2019 practice guidance and guidelines from the American Association for the Study of Liver Diseases","volume":"72","author":"Mack","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.autrev.2025.103806_bb0640","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jaut.2012.12.003","article-title":"T-regs in autoimmune hepatitis-systemic lupus erythematosus\/mixed connective tissue disease overlap syndrome are functionally defective and display a Th1 cytokine profile","volume":"41","author":"Longhi","year":"2013","journal-title":"J Autoimmun"},{"issue":"1","key":"10.1016\/j.autrev.2025.103806_bb0645","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3109\/08916931003782163","article-title":"Therapeutic potential of TGF-\u03b2-induced CD4+ Foxp3+ regulatory T cells in autoimmune diseases","volume":"44","author":"Zhou","year":"2011","journal-title":"Autoimmunity"},{"key":"10.1016\/j.autrev.2025.103806_bb0650","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2021.102619","article-title":"Regulatory T cells in autoimmune hepatitis: an updated overview","volume":"119","author":"Longhi","year":"2021","journal-title":"J Autoimmun"},{"issue":"2","key":"10.1016\/j.autrev.2025.103806_bb0655","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.jhep.2010.10.005","article-title":"Liver antigen-presenting cells","volume":"54","author":"Crispe","year":"2011","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.autrev.2025.103806_bb0660","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1053\/jhep.2003.50191","article-title":"MHC class II-expressing hepatocytes function as antigen-presenting cells and activate specific CD4 T lymphocyutes","volume":"37","author":"Herkel","year":"2003","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.autrev.2025.103806_bb0665","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/hep.1840120208","article-title":"Class I and class II major histocompatibility complex antigen expression on hepatocytes: a study in children with liver disease","volume":"12","author":"Lobo-Yeo","year":"1990","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.autrev.2025.103806_bb0670","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/0090-1229(90)90052-R","article-title":"Liver-derived T cell clones in autoimmune chronic active hepatitis: accessory cell function of hepatocytes expressing class II major histocompatibility complex molecules","volume":"54","author":"Franco","year":"1990","journal-title":"Clin Immunol Immunopathol"},{"issue":"3","key":"10.1016\/j.autrev.2025.103806_bb0675","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1073\/pnas.75.3.1549","article-title":"Alteration in suppressor cell activity in chronic active hepatitis*","volume":"75","author":"Hodgson","year":"1978","journal-title":"Proc Natl Acad Sci"},{"issue":"21","key":"10.1016\/j.autrev.2025.103806_bb0680","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJM198211183072102","article-title":"Effect of corticosteroids on suppressor-cell activity in autoimmune and viral chronic active hepatitis","volume":"307","author":"Nouri-Aria","year":"1982","journal-title":"N Engl J Med"},{"issue":"8388","key":"10.1016\/j.autrev.2025.103806_bb0685","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/S0140-6736(84)91691-X","article-title":"Antigen specific suppressor cell function in autoimmune chronic active hepatitis","volume":"323","author":"Vento","year":"1984","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.autrev.2025.103806_bb0690","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1053\/jhep.2001.22131","article-title":"Autoimmune hepatitis\/sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study","volume":"33","author":"Gregorio","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.autrev.2025.103806_bb0695","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jaut.2018.10.008","article-title":"Autoimmune sclerosing cholangitis: evidence and open questions","volume":"95","author":"Terziroli Beretta-Piccoli","year":"2018","journal-title":"J Autoimmun"},{"issue":"1","key":"10.1016\/j.autrev.2025.103806_bb0700","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jaut.2005.05.001","article-title":"Effect of CD4+CD25+ regulatory T-cells on CD8 T-cell function in patients with autoimmune hepatitis","volume":"25","author":"Longhi","year":"2005","journal-title":"J Autoimmun"},{"issue":"7","key":"10.1016\/j.autrev.2025.103806_bb0705","doi-asserted-by":"crossref","first-page":"4484","DOI":"10.4049\/jimmunol.176.7.4484","article-title":"Functional study of CD4+CD25+ regulatory T cells in health and autoimmune hepatitis","volume":"176","author":"Longhi","year":"2006","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.autrev.2025.103806_bb0710","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/hep.22914","article-title":"Vigorous activation of monocytes in juvenile autoimmune liver disease escapes the control of regulatory T-cells","volume":"50","author":"Longhi","year":"2009","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.autrev.2025.103806_bb0715","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1002\/hep.23792","article-title":"A multifaceted imbalance of T cells with regulatory function characterizes type 1 autoimmune hepatitis","volume":"52","author":"Ferri","year":"2010","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.autrev.2025.103806_bb0720","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.jhep.2014.05.034","article-title":"Intrahepatic regulatory T cells in autoimmune hepatitis are associated with treatment response and depleted with current therapies","volume":"61","author":"Taubert","year":"2014","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.autrev.2025.103806_bb0725","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/hep.25682","article-title":"The impaired immune regulation of autoimmune hepatitis is linked to a defective galectin-9\/tim-3 pathway","volume":"56","author":"Liberal","year":"2012","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.autrev.2025.103806_bb0730","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1002\/hep.26583","article-title":"Dysfunctional CD39(POS) regulatory T cells and aberrant control of T-helper type 17 cells in autoimmune hepatitis","volume":"59","author":"Grant","year":"2014","journal-title":"Hepatology"},{"issue":"11","key":"10.1016\/j.autrev.2025.103806_bb0735","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1016\/j.ymthe.2020.07.020","article-title":"CD4+CD126low\/\u2212 Foxp3+ cell population represents a superior subset of regulatory T cells in treating autoimmune diseases","volume":"28","author":"Chen","year":"2020","journal-title":"Mol Ther"},{"issue":"1","key":"10.1016\/j.autrev.2025.103806_bb0740","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jhep.2020.06.044","article-title":"Altered aryl-hydrocarbon-receptor signalling affects regulatory and effector cell immunity in autoimmune hepatitis","volume":"74","author":"Vuerich","year":"2021","journal-title":"J Hepatol"},{"issue":"9","key":"10.1016\/j.autrev.2025.103806_bb0745","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/ni.1915","article-title":"Activation of the aryl hydrocarbon receptor induces human type 1 regulatory T cell\u2013like and Foxp3+ regulatory T cells","volume":"11","author":"Gandhi","year":"2010","journal-title":"Nat Immunol"},{"issue":"7191","key":"10.1016\/j.autrev.2025.103806_bb0750","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/nature06880","article-title":"Control of Treg and TH17 cell differentiation by the aryl hydrocarbon receptor","volume":"453","author":"Quintana","year":"2008","journal-title":"Nature"},{"issue":"7191","key":"10.1016\/j.autrev.2025.103806_bb0755","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nature06881","article-title":"The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins","volume":"453","author":"Veldhoen","year":"2008","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.autrev.2025.103806_bb0760","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0181107","article-title":"Pediatric autoimmune hepatitis shows a disproportionate decline of regulatory T cells in the liver and of IL-2 in the blood of patients undergoing therapy","volume":"12","author":"Diestelhorst","year":"2017","journal-title":"PloS One"},{"issue":"1","key":"10.1016\/j.autrev.2025.103806_bb0765","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/s41392-017-0002-5","article-title":"Targeting IL-2: an unexpected effect in treating immunological diseases","volume":"3","author":"Ye","year":"2018","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.autrev.2025.103806_bb0770","first-page":"1527","article-title":"Expansion and de novo generation of potentially therapeutic regulatory T cells in patients with autoimmune hepatitis","author":"Longhi","year":"2025","journal-title":"Electronic"},{"issue":"7","key":"10.1016\/j.autrev.2025.103806_bb0775","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1053\/j.gastro.2012.02.041","article-title":"Inhibition of Interleukin-17 promotes differentiation of CD25\u2013 cells into stable T regulatory cells in patients with autoimmune hepatitis","volume":"142","author":"Longhi","year":"2012","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.autrev.2025.103806_bb0780","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.jhepr.2019.08.001","article-title":"Liver homing of clinical grade Tregs after therapeutic infusion in patients with autoimmune hepatitis","volume":"1","author":"Oo","year":"2019","journal-title":"JHEP Rep"},{"issue":"2","key":"10.1016\/j.autrev.2025.103806_bb0785","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s12072-010-9183-5","article-title":"Autoimmune hepatitis: new paradigms in the pathogenesis, diagnosis, and management","volume":"4","author":"Oo","year":"2010","journal-title":"Hepatol Int"},{"issue":"2","key":"10.1016\/j.autrev.2025.103806_bb0790","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1002\/JLB.5MR0320-200R","article-title":"Immune system and cholangiocytes: a puzzling affair in primary biliary cholangitis","volume":"108","author":"Ronca","year":"2020","journal-title":"J Leukoc Biol"},{"issue":"9904","key":"10.1016\/j.autrev.2025.103806_bb0795","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/S0140-6736(13)60096-3","article-title":"Primary sclerosing cholangitis","volume":"382","author":"Hirschfield","year":"2013","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.autrev.2025.103806_bb0800","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/BF00915293","article-title":"T-lymphocyte subsets in liver tissues of patients with primary biliary cirrhosis (PBC), patients with primary sclerosing cholangitis (PSC), and normal controls","volume":"4","author":"Si","year":"1984","journal-title":"J Clin Immunol"},{"issue":"3","key":"10.1016\/j.autrev.2025.103806_bb0805","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/nri1784","article-title":"Aberrant homing of mucosal T cells and extra-intestinal manifestations of inflammatory bowel disease","volume":"6","author":"Adams","year":"2006","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"10.1016\/j.autrev.2025.103806_bb0810","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.autrev.2005.01.005","article-title":"T cell immunity in autoimmune hepatitis","volume":"4","author":"Ichiki","year":"2005","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2025.103806_bb0815","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2019.06.004","article-title":"Cytotoxic KLRG1 expressing lymphocytes invade portal tracts in primary biliary cholangitis","volume":"103","author":"Li","year":"2019","journal-title":"J Autoimmun"},{"issue":"10","key":"10.1016\/j.autrev.2025.103806_bb0820","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1002\/eji.201040839","article-title":"Tolerogenic plasmacytoid DC","volume":"40","author":"Matta","year":"2010","journal-title":"Eur J Immunol"},{"issue":"6","key":"10.1016\/j.autrev.2025.103806_bb0825","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1136\/gutjnl-2017-314184","article-title":"CD14+ CD15- HLA-DR- myeloid-derived suppressor cells impair antimicrobial responses in patients with acute-on-chronic liver failure","volume":"67","author":"Christine","year":"2018","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.autrev.2025.103806_bb0830","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1136\/gut.2003.020263","article-title":"Natural history of compensated viral cirrhosis: a prospective study on the incidence and hierarchy of major complications","volume":"53","author":"Benvegn\u00f9","year":"2004","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.autrev.2025.103806_bb0835","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/0016-5085(86)90680-3","article-title":"T-lymphocyte sensitization to hepatocyte antigens in autoimmune chronic active hepatitis and primary biliary cirrhosis: evidence for different underlying mechanisms and different antigenic determinants as targets","volume":"91","author":"Vento","year":"1986","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.autrev.2025.103806_bb0840","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/hep.21123","article-title":"Liver-targeted and peripheral blood alterations of regulatory T cells in primary biliary cirrhosis","volume":"43","author":"Lan","year":"2006","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.autrev.2025.103806_bb0845","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/cmi.2010.40","article-title":"CD4+CD25+ but not CD4+Foxp3+ T cells as a regulatory subset in primary biliary cirrhosis","volume":"7","author":"Wang","year":"2010","journal-title":"Cell Mol Immunol"},{"issue":"2","key":"10.1016\/j.autrev.2025.103806_bb0850","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1365-2249.2009.03898.x","article-title":"Imbalance between T helper type 17 and T regulatory cells in patients with primary biliary cirrhosis: the serum cytokine profile and peripheral cell population","volume":"156","author":"Rong","year":"2009","journal-title":"Clin Exp Immunol"},{"issue":"3","key":"10.1016\/j.autrev.2025.103806_bb0855","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jaut.2010.06.004","article-title":"Phenotypical and functional alterations of CD8 regulatory T cells in primary biliary cirrhosis","volume":"35","author":"Bernuzzi","year":"2010","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2025.103806_bb0860","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.00031","article-title":"CD28\u2212 and CD28lowCD8+ regulatory T cells: of mice and men","volume":"8","author":"Vuddamalay","year":"2017","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.autrev.2025.103806_bb0865","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/jmcb\/mjt026","article-title":"Phenotypic and functional characteristic of a newly identified CD8+Foxp3\u2212CD103+ regulatory T cells","volume":"6","author":"Liu","year":"2014","journal-title":"J Mol Cell Biol"},{"key":"10.1016\/j.autrev.2025.103806_bb0870","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.00035","article-title":"TGF-\u03b2-induced CD8+CD103+ regulatory T cells show potent therapeutic effect on chronic graft-versus-host disease lupus by suppressing B cells","volume":"9","author":"Zhong","year":"2018","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.autrev.2025.103806_bb0875","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1002\/hep.21385","article-title":"IL-2 receptor alpha(\u2212\/\u2212) mice and the development of primary biliary cirrhosis","volume":"44","author":"Wakabayashi","year":"2006","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.autrev.2025.103806_bb0880","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1002\/hep.22651","article-title":"Deficiency in regulatory T cells results in development of antimitochondrial antibodies and autoimmune cholangitis","volume":"49","author":"Zhang","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.autrev.2025.103806_bb0885","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jaut.2014.01.034","article-title":"Murine autoimmune cholangitis requires two hits: cytotoxic KLRG1+ CD8 effector cells and defective T regulatory cells","volume":"50","author":"Huang","year":"2014","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2025.103806_bb0890","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jaut.2015.01.011","article-title":"Systems biologic analysis of T regulatory cells genetic pathways in murine primary biliary cirrhosis","volume":"59","author":"Wang","year":"2015","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2025.103806_bb0895","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jaut.2018.07.020","article-title":"Increased sensitivity of Treg cells from patients with PBC to low dose IL-12 drives their differentiation into IFN-\u03b3 secreting cells","volume":"94","author":"Liaskou","year":"2018","journal-title":"J Autoimmun"},{"issue":"5","key":"10.1016\/j.autrev.2025.103806_bb0900","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.jhep.2013.12.027","article-title":"Reduced FOXP3+ regulatory T cells in patients with primary sclerosing cholangitis are associated with IL2RA gene polymorphisms","volume":"60","author":"Sebode","year":"2014","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.autrev.2025.103806_bb0905","doi-asserted-by":"crossref","DOI":"10.1002\/hep.30061","article-title":"Interleukin 2 promotes hepatic regulatory T cell responses and protects from biliary fibrosis in murine Sclerosing cholangitis","volume":"68","author":"Taylor","year":"2018","journal-title":"Hepatology"},{"issue":"7053","key":"10.1016\/j.autrev.2025.103806_bb0910","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1038\/nature04079","article-title":"Adaptive immune responses in acute and chronic hepatitis C virus infection","volume":"436","author":"Bowen","year":"2005","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.autrev.2025.103806_bb0915","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1146\/annurev.immunol.25.022106.141602","article-title":"Flying under the radar: the Immunobiology of hepatitis C","volume":"25","author":"Dustin","year":"2007","journal-title":"Annu Rev Immunol"},{"issue":"15","key":"10.1016\/j.autrev.2025.103806_bb0920","doi-asserted-by":"crossref","first-page":"9369","DOI":"10.1128\/JVI.79.15.9369-9380.2005","article-title":"Stealth and cunning: hepatitis B and hepatitis C viruses","volume":"79","author":"Wieland Stefan","year":"2005","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.autrev.2025.103806_bb0925","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1146\/annurev.pathol.1.110304.100230","article-title":"Immunobiology and pathogenesis of viral hepatitis","volume":"1","author":"Guidotti","year":"2006","journal-title":"Annu Rev Pathol Mech Dis"},{"issue":"2","key":"10.1016\/j.autrev.2025.103806_bb0930","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1002\/hep.27323","article-title":"Immunological aspects of antiviral therapy of chronic hepatitis B virus and hepatitis C virus infections","volume":"61","author":"Rehermann","year":"2015","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.autrev.2025.103806_bb0935","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.smim.2011.10.002","article-title":"Two modes of immune suppression by Foxp3+ regulatory T cells under inflammatory or non-inflammatory conditions","volume":"23","author":"Yamaguchi","year":"2011","journal-title":"Semin Immunol"},{"issue":"8","key":"10.1016\/j.autrev.2025.103806_bb0940","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/nri.2016.69","article-title":"Immune responses and immunopathology in acute and chronic viral hepatitis","volume":"16","author":"Shin","year":"2016","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"10.1016\/j.autrev.2025.103806_bb0945","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s10875-011-9509-7","article-title":"Circulating Tregs correlate with viral load reduction in chronic HBV-treated patients with Tenofovir Disoproxil fumarate","volume":"31","author":"TrehanPati","year":"2011","journal-title":"J Clin Immunol"},{"issue":"4","key":"10.1016\/j.autrev.2025.103806_bb0950","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1002\/hep.20649","article-title":"Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection","volume":"41","author":"Stoop","year":"2005","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.autrev.2025.103806_bb0955","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1093\/infdis\/jis011","article-title":"Dissection of a circulating and intrahepatic CD4+Foxp3+ T-cell subpopulation in chronic hepatitis B virus (HBV) infection: a highly informative strategy for distinguishing chronic HBV infection states","volume":"205","author":"Zhang","year":"2012","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.autrev.2025.103806_bb0960","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/ni1181","article-title":"Natural regulatory T cells in infectious disease","volume":"6","author":"Belkaid","year":"2005","journal-title":"Nat Immunol"},{"issue":"11","key":"10.1016\/j.autrev.2025.103806_bb0965","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1038\/nri1485","article-title":"Regulatory T cells: friend or foe in immunity to infection?","volume":"4","author":"Mills","year":"2004","journal-title":"Nat Rev Immunol"},{"issue":"12","key":"10.1016\/j.autrev.2025.103806_bb0970","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/S1473-3099(07)70289-X","article-title":"T-cell regulation by CD4 regulatory T cells during hepatitis B and C virus infections: facts and controversies","volume":"7","author":"Manigold","year":"2007","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"10.1016\/j.autrev.2025.103806_bb0975","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s10875-011-9509-7","article-title":"Circulating Tregs correlate with viral load reduction in chronic HBV-treated patients with tenofovir disoproxil fumarate","volume":"31","author":"TrehanPati","year":"2011","journal-title":"J Clin Immunol"},{"issue":"6","key":"10.1016\/j.autrev.2025.103806_bb0980","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.1128\/JVI.79.6.3322-3328.2005","article-title":"Modulation of the CD8+-T-cell response by CD4+ CD25+ regulatory T cells in patients with hepatitis B virus infection","volume":"79","author":"Franzese","year":"2005","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.autrev.2025.103806_bb0985","doi-asserted-by":"crossref","first-page":"739","DOI":"10.4049\/jimmunol.177.1.739","article-title":"Circulating and liver resident CD4+CD25+ regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis B","volume":"177","author":"Xu","year":"2006","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.autrev.2025.103806_bb0990","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.virol.2006.11.018","article-title":"Inhibition of viral replication reduces regulatory T cells and enhances the antiviral immune response in chronic hepatitis B","volume":"361","author":"Stoop","year":"2007","journal-title":"Virology"},{"issue":"2","key":"10.1016\/j.autrev.2025.103806_bb0995","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1093\/intimm\/dxl130","article-title":"Association of CD4+CD25+Foxp3+ regulatory T cells with chronic activity and viral clearance in patients with hepatitis B","volume":"19","author":"Yang","year":"2007","journal-title":"Int Immunol"},{"issue":"9","key":"10.1016\/j.autrev.2025.103806_bb1000","doi-asserted-by":"crossref","first-page":"5149","DOI":"10.4049\/jimmunol.172.9.5149","article-title":"Cutting edge: TGF-\u03b2 induces a regulatory phenotype in CD4+CD25\u2212 T cells through Foxp3 induction and Down-regulation of Smad7","volume":"172","author":"Fantini","year":"2004","journal-title":"J Immunol"},{"issue":"10","key":"10.1016\/j.autrev.2025.103806_bb1005","doi-asserted-by":"crossref","first-page":"5549","DOI":"10.4049\/jimmunol.1003917","article-title":"Hepatic stellate cells function as regulatory bystanders","volume":"186","author":"Ichikawa","year":"2011","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.autrev.2025.103806_bb1010","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1086\/523651","article-title":"Functional suppression by FoxP3+CD4+CD25high regulatory T cells during acute hepatitis C virus infection","volume":"197","author":"Pearson","year":"2008","journal-title":"J Infect Dis"},{"issue":"10","key":"10.1016\/j.autrev.2025.103806_bb1015","doi-asserted-by":"crossref","first-page":"5043","DOI":"10.1128\/JVI.01548-07","article-title":"Identification and in vitro expansion of functional antigen-specific CD25+ FoxP3+ regulatory T cells in hepatitis C virus infection","volume":"82","author":"Ebinuma","year":"2008","journal-title":"J Virol"},{"issue":"6","key":"10.1016\/j.autrev.2025.103806_bb1020","first-page":"1437","article-title":"Suppression of HCV-specific T cells without differential hierarchy demonstrated ex vivo in persistent HCV infection","volume":"38","author":"Sugimoto","year":"2003","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.autrev.2025.103806_bb1025","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1128\/JVI.01768-07","article-title":"Natural regulatory T cells and persistent viral infection","volume":"82","author":"Li","year":"2008","journal-title":"J Virol"},{"issue":"12","key":"10.1016\/j.autrev.2025.103806_bb1030","doi-asserted-by":"crossref","first-page":"7852","DOI":"10.1128\/JVI.79.12.7852-7859.2005","article-title":"Regulatory T cells suppress in vitro proliferation of virus-specific CD8+ T cells during persistent hepatitis C virus infection","volume":"79","author":"Rushbrook Simon","year":"2005","journal-title":"J Virol"},{"issue":"3","key":"10.1016\/j.autrev.2025.103806_bb1035","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.jhep.2007.03.023","article-title":"Quantification and localisation of FOXP3+ T lymphocytes and relation to hepatic inflammation during chronic HCV infection","volume":"47","author":"Ward","year":"2007","journal-title":"J Hepatol"},{"issue":"12","key":"10.1016\/j.autrev.2025.103806_bb1040","doi-asserted-by":"crossref","first-page":"7860","DOI":"10.1128\/JVI.79.12.7860-7867.2005","article-title":"T cells with a CD4+CD25+ regulatory phenotype suppress in vitro proliferation of virus-specific CD8+ T cells during chronic hepatitis C virus infection","volume":"79","author":"Boettler","year":"2005","journal-title":"J Virol"},{"issue":"3","key":"10.1016\/j.autrev.2025.103806_bb1045","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jhep.2009.12.013","article-title":"Abundant numbers of regulatory T cells localize to the liver of chronic hepatitis C infected patients and limit the extent of fibrosis","volume":"52","author":"Claassen","year":"2010","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.autrev.2025.103806_bb1050","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1365-2249.2006.03048.x","article-title":"Increased hepatitis C virus (HCV)-specific CD4+CD25+ regulatory T lymphocytes and reduced HCV-specific CD4+ T cell response in HCV-infected patients with normal versus abnormal alanine aminotransferase levels","volume":"144","author":"Bolacchi","year":"2006","journal-title":"Clin Exp Immunol"},{"issue":"3","key":"10.1016\/j.autrev.2025.103806_bb1055","first-page":"889","article-title":"CD19(+)CD24(hi)CD38(hi) regulatory B cells: a potential immune predictive marker of severity and therapeutic responsiveness of hepatitis C","volume":"12","author":"Fang","year":"2020","journal-title":"Am J Transl Res"},{"issue":"8","key":"10.1016\/j.autrev.2025.103806_bb1060","article-title":"Understanding the cellular interactome of non-alcoholic fatty liver disease","volume":"4","author":"Wallace","year":"2022","journal-title":"JHEP Rep"},{"issue":"13","key":"10.1016\/j.autrev.2025.103806_bb1065","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1080\/14656566.2020.1774553","article-title":"Current and emerging pharmacotherapeutic interventions for the treatment of liver fibrosis","volume":"21","author":"Lambrecht","year":"2020","journal-title":"Expert Opin Pharmacother"},{"issue":"14","key":"10.1016\/j.autrev.2025.103806_bb1070","doi-asserted-by":"crossref","DOI":"10.1172\/JCI157780","article-title":"Distinct histopathological phenotypes of severe alcoholic hepatitis suggest different mechanisms driving liver injury and failure","volume":"132","author":"Ma","year":"2022","journal-title":"J Clin Invest"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997225000667?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997225000667?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T22:07:18Z","timestamp":1762553238000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997225000667"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":214,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S1568997225000667"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2025.103806","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of regulatory T cells in inflammatory liver diseases","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2025.103806","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103806"}}